These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 34117242)

  • 1. Analysis of the genomic landscape of yolk sac tumors reveals mechanisms of evolution and chemoresistance.
    Zong X; Zhang Y; Peng X; Cao D; Yu M; Wang J; Li H; Guo X; Liang H; Yang J
    Nat Commun; 2021 Jun; 12(1):3579. PubMed ID: 34117242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole-exome sequencing reveals potential germline and somatic mutations in 60 malignant ovarian germ cell tumors†.
    Chen J; Li Y; Wu J; Liu Y; Kang S
    Biol Reprod; 2021 Jul; 105(1):164-178. PubMed ID: 33739378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pioneer and differentiation factor FOXA2 is a key driver of yolk-sac tumour formation and a new biomarker for paediatric and adult yolk-sac tumours.
    Wruck W; Bremmer F; Kotthoff M; Fichtner A; Skowron MA; Schönberger S; Calaminus G; Vokuhl C; Pfister D; Heidenreich A; Albers P; Adjaye J; Nettersheim D
    J Cell Mol Med; 2021 Feb; 25(3):1394-1405. PubMed ID: 33448076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The genetic landscape of 87 ovarian germ cell tumors.
    Van Nieuwenhuysen E; Busschaert P; Neven P; Han SN; Moerman P; Liontos M; Papaspirou M; Kupryjanczyk J; Hogdall C; Hogdall E; Oaknin A; Garcia A; Mahner S; Trillsch F; Cibula D; Heitz F; Concin N; Speiser P; Salvesen H; Sehouli J; Lambrechts D; Vergote I
    Gynecol Oncol; 2018 Oct; 151(1):61-68. PubMed ID: 30170975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorescent In Situ Hybridization Analysis for 12p Alterations in Sarcomatoid Yolk Sac Tumors.
    Idrees MT; Ulbright TM; Epstein JI
    Am J Surg Pathol; 2019 Nov; 43(11):1566-1573. PubMed ID: 31478941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylator phenotype of malignant germ cell tumours in children identifies strong candidates for chemotherapy resistance.
    Jeyapalan JN; Noor DA; Lee SH; Tan CL; Appleby VA; Kilday JP; Palmer RD; Schwalbe EC; Clifford SC; Walker DA; Murray MJ; Coleman N; Nicholson JC; Scotting PJ
    Br J Cancer; 2011 Aug; 105(4):575-85. PubMed ID: 21712824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary germ cell tumors of the mediastinum: III. Yolk sac tumor, embryonal carcinoma, choriocarcinoma, and combined nonteratomatous germ cell tumors of the mediastinum--a clinicopathologic and immunohistochemical study of 64 cases.
    Moran CA; Suster S; Koss MN
    Cancer; 1997 Aug; 80(4):699-707. PubMed ID: 9264353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive genetic analysis of pediatric germ cell tumors identifies potential drug targets.
    Kubota Y; Seki M; Kawai T; Isobe T; Yoshida M; Sekiguchi M; Kimura S; Watanabe K; Sato-Otsubo A; Yoshida K; Suzuki H; Kataoka K; Fujii Y; Shiraishi Y; Chiba K; Tanaka H; Hiwatari M; Oka A; Hayashi Y; Miyano S; Ogawa S; Hata K; Tanaka Y; Takita J
    Commun Biol; 2020 Sep; 3(1):544. PubMed ID: 32999426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic analysis of low-grade serous ovarian carcinoma to identify key drivers and therapeutic vulnerabilities.
    Cheasley D; Nigam A; Zethoven M; Hunter S; Etemadmoghadam D; Semple T; Allan P; Carey MS; Fernandez ML; Dawson A; Köbel M; Huntsman DG; Le Page C; Mes-Masson AM; Provencher D; Hacker N; Gao Y; Bowtell D; deFazio A; Gorringe KL; Campbell IG
    J Pathol; 2021 Jan; 253(1):41-54. PubMed ID: 32901952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of vasculogenic mesenchymal tumor in the mediastinum: whole-exome sequencing reveals origin from pre-existing germ cell tumor.
    Fujii H; Yamada Y; Yamamura K; Ishida Y; Tsujimura M; Matsumoto K; Tanaka S; Date H; Nishikawa T; Yoshida Y; Kashima J; Yatabe Y; Ogawa S; Marx A; Ulbright TM; Haga H
    Virchows Arch; 2023 May; 482(5):923-927. PubMed ID: 36943470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment of cisplatin-resistant ovarian yolk sac tumor cells and investigation of the mechanism of cisplatin resistance using this cell line.
    Shibata K; Umezu T; Sakurai M; Kajiyama H; Yamamoto E; Ino K; Nawa A; Kikkawa F
    Gynecol Obstet Invest; 2011; 71(2):104-11. PubMed ID: 21150160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of HNF1β in the differential diagnosis of yolk sac tumor from other germ cell tumors.
    Rougemont AL; Tille JC
    Hum Pathol; 2018 Nov; 81():26-36. PubMed ID: 29753846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SALL4 is a novel sensitive and specific marker of ovarian primitive germ cell tumors and is particularly useful in distinguishing yolk sac tumor from clear cell carcinoma.
    Cao D; Guo S; Allan RW; Molberg KH; Peng Y
    Am J Surg Pathol; 2009 Jun; 33(6):894-904. PubMed ID: 19295406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging in gynecological disease (17): ultrasound features of malignant ovarian yolk sac tumors (endodermal sinus tumors).
    Anfelter P; Testa A; Chiappa V; Froyman W; Fruscio R; Guerriero S; Alcazar JL; Mascillini F; Pascual MA; Sibal M; Savelli L; Zannoni GF; Timmerman D; Epstein E
    Ultrasound Obstet Gynecol; 2020 Aug; 56(2):276-284. PubMed ID: 32119168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brief Report: A Second Primary Endodermal Sinus Tumor 9 Years after Initial Diagnosis.
    Moukarzel LA; Levinson K; Grumbine FC
    J Pediatr Adolesc Gynecol; 2017 Apr; 30(2):259-261. PubMed ID: 27818263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting CLDN6 in germ cell tumors by an antibody-drug-conjugate and studying therapy resistance of yolk-sac tumors to identify and screen specific therapeutic options.
    Skowron MA; Kotthoff M; Bremmer F; Ruhnke K; Parmaksiz F; Richter A; Küffer S; Reuter-Jessen K; Pauls S; Stefanski A; Ströbel P; Stühler K; Nettersheim D
    Mol Med; 2023 Mar; 29(1):40. PubMed ID: 36991316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment and Characterization of a Novel Primitive Yolk Sac Tumour Cell Line, TC587.
    Iwasaki T; Kohashi K; Ohno M; Taguchi T; Oda Y
    Anticancer Res; 2020 Feb; 40(2):759-766. PubMed ID: 32014918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of chromosome aberrations in paraffin sections of seven gonadal yolk sac tumors of childhood.
    Jenderny J; Köster E; Meyer A; Borchers O; Grote W; Harms D; Jänig U
    Hum Genet; 1995 Dec; 96(6):644-50. PubMed ID: 8522320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of adenomatous polyposis coli (APC) gene in testicular yolk sac tumor of infants.
    Kato N; Shibuya H; Fukase M; Tamura G; Motoyama T
    Hum Pathol; 2006 Jan; 37(1):48-53. PubMed ID: 16360415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of cytokeratin 7 and EMA in differentiating ovarian yolk sac tumors from endometrioid and clear cell carcinomas.
    Ramalingam P; Malpica A; Silva EG; Gershenson DM; Liu JL; Deavers MT
    Am J Surg Pathol; 2004 Nov; 28(11):1499-505. PubMed ID: 15489654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.